December 16, 2021

ImmuneWatch releases white paper evaluating the effect of mutations gathered in the SARS-COV-2 Omicron variant on T cell immunity

Omicron, the latest SARS-COV-2 variant of concern is characterized by a large number of mutations. In our first white paper, we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.

Download the Whitepaper

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

July 29, 2024

ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI

ImmuneWatch, a Belgian university spinoff specialising in monitoring and predicting immune responses, has been awarded an innovation grant of € 94.000 from the city of Antwerp.

July 29, 2024

ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

ImmuneWatch, Quantoom Biosciences (“Quantoom”) and UAntwerp (Lab of Experimental Hematology) are delighted to announce a public-private partnership in a project under the “Pandemic Preparedness” call, launched by the University of Antwerp in 2022.